UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
USDC Liquidity Availability outlines current access across exchanges and wallets, helping you plan trades and allocations effectively.
13,627 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
The U.S. Treasury’s latest report signals a nuanced path for crypto privacy within regulated markets, hinting at supe...
Unlock a practical framework for interpreting bridger aerospace (BAER) earnings. This guide breaks down revenue drive...
Intel remains the Dow's most shorted stock as fresh data show rising short interest amid continued cash burn in the f...
Investors are parsing sector headlines as analysts cut targets for airlines and other cyclical stocks. This guide bre...
Geopolitics around Iran’s Strait Hormuz could reshape energy prices in Europe again. Here’s what households need to k...
Forbes' 2026 Billionaires List puts Binance founder CZ ahead of Bill Gates, prompting debate over crypto wealth and h...
When choosing where to park money or borrow, the smart move may be to use both banks. Dave Ramsey weighs Navy Federal...
Goldman Sachs now puts a one-year recession probability at about 25%. Here’s how that signal, plus energy volatility ...
When a top executive makes bold moves with his own money, it’s hard not to notice. This article dives into what berks...
Fresh money data in 2026 contests one core debt strategy from Dave Ramsey, while underscoring the value of discipline...
Tesla sits near the $400 mark as investors weigh future growth against current prices. This guide helps you decide wh...